Hartman-Adams H, Banvard C, Juckett G. Impetigo: diagnosis and treatment. Am Fam Physician. 2014;90(4):229-235. PMID:25250996

Schachner LA, Andriessen A, Benjamin LT, et al. Do antimicrobial resistance patterns matter? An algorithm for the treatment of patients with impetigo. J Drugs Dermatol. 2021;20(2):134-142. https://doi.org/10.36849/JDD.5745 PMID:33538559

Gropper S, Albareda N, Chelius K, et al; Ozenoxacin in Impetigo Trial Investigators Group. Ozenoxacin 1% cream in the treatment of impetigo: a multicenter, randomized, placebo- and retapamulin-controlled clinical trial. Future Microbiol. 2014;9(9):1013-1023. https://doi.org/10.2217/fmb.14.78 PMID:25340832

Rosen T, Albareda N, Rosenberg N, et al. Efficacy and safety of ozenoxacin cream for treatment of adult and pediatric patients with impetigo: a randomized clinical trial. JAMA Dermatol. 2018;154(7):806-813. https://doi.org/10.1001/jamadermatol.2018.1103PMID:29898217

Wren C, Bell E, Eiland LS. Ozenoxacin: A novel topical quinolone for impetigo. Ann Pharmacother. 2018;52(12):1233-1237. https://doi.org/10.1177/1060028018786510PMID:29962213

Sicras-Mainar A, Enriquez JL, Hernández I, Sicras-Navarro A, Aymerich T, Leon M. PMU146 validation and representativeness of the Spanish BIG-PAC database: integrated computerized medical records for research into epidemiology, medicines and health resource use (real world evidence). Value Health. 2019;22:S734. https://doi.org/10.1016/j.jval.2019.09.1764

Instituto Nacional de Estadística. Average wage by sex and age. Online https://www.ine.es/dynt3/inebase/index.htm?padre=4563&capsel=4563 (Accessed May 2022)